167 related articles for article (PubMed ID: 16390892)
1. Psychomotor slowing as a predictor of fluoxetine nonresponse in depressed outpatients.
Taylor BP; Bruder GE; Stewart JW; McGrath PJ; Halperin J; Ehrlichman H; Quitkin FM
Am J Psychiatry; 2006 Jan; 163(1):73-8. PubMed ID: 16390892
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychological characteristics as predictors of SSRI treatment response in depressed subjects.
Gorlyn M; Keilp JG; Grunebaum MF; Taylor BP; Oquendo MA; Bruder GE; Stewart JW; Zalsman G; Mann JJ
J Neural Transm (Vienna); 2008 Aug; 115(8):1213-9. PubMed ID: 18629432
[TBL] [Abstract][Full Text] [Related]
3. Change in cognitive functioning following acute antidepressant treatment in late-life depression.
Culang ME; Sneed JR; Keilp JG; Rutherford BR; Pelton GH; Devanand DP; Roose SP
Am J Geriatr Psychiatry; 2009 Oct; 17(10):881-8. PubMed ID: 19916207
[TBL] [Abstract][Full Text] [Related]
4. A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients.
Sechter D; Troy S; Paternetti S; Boyer P
Eur Psychiatry; 1999 Mar; 14(1):41-8. PubMed ID: 10572324
[TBL] [Abstract][Full Text] [Related]
5. Executive dysfunction predicts nonresponse to fluoxetine in major depression.
Dunkin JJ; Leuchter AF; Cook IA; Kasl-Godley JE; Abrams M; Rosenberg-Thompson S
J Affect Disord; 2000 Oct; 60(1):13-23. PubMed ID: 10940443
[TBL] [Abstract][Full Text] [Related]
6. Controlled double-blind trial of phenytoin vs. fluoxetine in major depressive disorder.
Nemets B; Bersudsky Y; Belmaker RH
J Clin Psychiatry; 2005 May; 66(5):586-90. PubMed ID: 15889944
[TBL] [Abstract][Full Text] [Related]
7. Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline.
Thase ME; Blomgren SL; Birkett MA; Apter JT; Tepner RG
J Clin Psychiatry; 1997 Jan; 58(1):16-21. PubMed ID: 9055832
[TBL] [Abstract][Full Text] [Related]
8. Algorithm-based treatment of major depression in an outpatient clinic: clinical correlates of response to a specific serotonin reuptake inhibitor and to triiodothyronine augmentation.
Agid O; Lerer B
Int J Neuropsychopharmacol; 2003 Mar; 6(1):41-9. PubMed ID: 12899735
[TBL] [Abstract][Full Text] [Related]
9. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
Goodyer IM; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
Health Technol Assess; 2008 May; 12(14):iii-iv, ix-60. PubMed ID: 18462573
[TBL] [Abstract][Full Text] [Related]
10. Residual symptoms in depressed patients who respond acutely to fluoxetine.
Nierenberg AA; Keefe BR; Leslie VC; Alpert JE; Pava JA; Worthington JJ; Rosenbaum JF; Fava M
J Clin Psychiatry; 1999 Apr; 60(4):221-5. PubMed ID: 10221281
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression.
Schatzberg A; Roose S
Am J Geriatr Psychiatry; 2006 Apr; 14(4):361-70. PubMed ID: 16582045
[TBL] [Abstract][Full Text] [Related]
12. The antidepressant treatment response index and treatment outcomes in a placebo-controlled trial of fluoxetine.
Hunter AM; Cook IA; Greenwald SD; Tran ML; Miyamoto KN; Leuchter AF
J Clin Neurophysiol; 2011 Oct; 28(5):478-82. PubMed ID: 21946361
[TBL] [Abstract][Full Text] [Related]
13. Switching to bupropion in fluoxetine-resistant major depressive disorder.
Fava M; Papakostas GI; Petersen T; Mahal Y; Quitkin F; Stewart J; McGrath P
Ann Clin Psychiatry; 2003 Mar; 15(1):17-22. PubMed ID: 12839429
[TBL] [Abstract][Full Text] [Related]
14. NEO-FFI factor scores as predictors of clinical response to fluoxetine in depressed outpatients.
Petersen T; Papakostas GI; Bottonari K; Iacoviello B; Alpert JE; Fava M; Nierenberg AA
Psychiatry Res; 2002 Jan; 109(1):9-16. PubMed ID: 11850046
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic mechanism of antidepressant action in depressed patients.
Willner P; Hale AS; Argyropoulos S
J Affect Disord; 2005 May; 86(1):37-45. PubMed ID: 15820269
[TBL] [Abstract][Full Text] [Related]
16. The response of psychotic-like symptoms to fluoxetine monotherapy in non-psychotic major depressive disorder.
Dording CM; Sinicropi-Yao L; Papakostas G; Matthews JD; Nierenberg AA; Fava M; Mischoulon D
Nord J Psychiatry; 2009; 63(5):420-5. PubMed ID: 19521922
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of interleukin-6 and serotonin as biomarkers to predict response to fluoxetine.
Manoharan A; Rajkumar RP; Shewade DG; Sundaram R; Muthuramalingam A; Paul A
Hum Psychopharmacol; 2016 May; 31(3):178-84. PubMed ID: 27018372
[TBL] [Abstract][Full Text] [Related]
18. Somatic symptoms in outpatients with major depressive disorder treated with fluoxetine.
Denninger JW; Papakostas GI; Mahal Y; Merens W; Alpert JE; Nierenberg AA; Yeung A; Fava M
Psychosomatics; 2006; 47(4):348-52. PubMed ID: 16844895
[TBL] [Abstract][Full Text] [Related]
19. Hypoactive sexual desire among depressed female patients treated with selective serotonin reuptake inhibitors: a comparison between escitalopram and fluoxetine.
Sidi H; Asmidar D; Hod R; Jaafar NR; Guan NC
Int J Psychiatry Clin Pract; 2012 Mar; 16(1):41-7. PubMed ID: 22122658
[TBL] [Abstract][Full Text] [Related]
20. Timing of onset of antidepressant response with fluoxetine treatment.
Nierenberg AA; Farabaugh AH; Alpert JE; Gordon J; Worthington JJ; Rosenbaum JF; Fava M
Am J Psychiatry; 2000 Sep; 157(9):1423-8. PubMed ID: 10964858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
